International Research in Chinese Medicine
International Research in Chinese Medicine. 2024; 4: (2) ; 10.12208/j.ircm.20240040 .
总浏览量: 281
四川省成都市青羊区第九人民医院 四川成都
*通讯作者: 龙承中,单位:四川省成都市青羊区第九人民医院 四川成都;
目的 观察分析对湿热蕴肺型细菌性肺炎和支原体肺炎患者实施甘露消毒丹加减治疗配合抗感染药物治疗的临床效果和应用价值。方法 采用回顾性研究方法,选择院内就诊的60例湿热蕴肺型细菌性肺炎和支原体肺炎患者(样本纳入例数:60例;样本纳入时间:2022年5月至2023年5月),以随机摸球为基础分组方式,分为对照、实验两个小组,观察例数高度一致。分别实施抗感染药物治疗,甘露消毒丹加减治疗+抗感染药物治疗。收集分析治疗效果。结果 与对照组相比,实验组治疗后炎症因子水平(IL-6/IL -4/hs-CRP/TNF -α)更低,治疗后的炎症持续时间(高热/咳嗽/痰中带血)更短,肺功能指标(FVC、FEV1、FEV1/FVC)更高(P<0.05)。结论 甘露消毒丹加减治疗配合抗感染药物治疗可以有效抑制湿热蕴肺型细菌性肺炎和支原体肺炎患者炎症反应,促进症状改善,促进肺功能恢复,有较高应用价值。
Objective To observe and analyze the clinical effect and application value of Ganlu Sanitizing Dan combined with anti-infective drugs in the treatment of patients with damp-heat pulmonary bacterial pneumonia and mycoplasma pneumonia. Methods A retrospective study was carried out to select 60 patients with damp-heat pneumopneumonic bacterial pneumonia and mycoplasma pneumonia (sample number: 60 cases; Sample inclusion time: May 2022 to May 2023) was divided into control and experimental groups based on random ball touching, and the number of observed cases was highly consistent. Anti-infective drug treatment, manna disinfection Dan plus plus plus anti-infective drug treatment were respectively implemented. The therapeutic effect was collected and analyzed. Results Compared with the control group, the experimental group had lower levels of inflammatory factors (IL-6/ IL-4 /hs-CRP/ TNF-α), shorter duration of inflammation (high fever/cough/blood in sputum), and higher lung function indexes (FVC, FEV1, FEV1/FVC) after treatment (P<0.05). Conclusion The treatment of Ganlu Sanijian combined with anti-infective drugs can effectively inhibit the inflammatory response of patients with damp-heat pneumopneumonic bacterial pneumonia and mycoplasma pneumonia, promote the improvement of symptoms, and promote the recovery of lung function, which has high application value.
[1] 曾召海.小儿支原体感染性肺炎采用阿奇霉素联合布地奈德治疗效果分析[J].中国药物与临床,2021,21(22): 3695 -3696.
[2] 王司允,陈俊俊,朱玉辉,李馨,张新茹.1例藤黄微球菌致感染性心内膜炎合并重症肺炎的药学监护[J].中国药房,2023,34(9):1137-1141.
[3] 王亮亮,王凯,曹继飞等.两种抗感染药物治疗重症肺炎的效果及炎症因子水平预后比较[J].河北医学,2024, 30(1): 153-157.
[4] 杨梦婕,周密.儿童肺炎支原体肺炎治疗药物如何选择[J].中国合理用药探索,2023,20(10):17-19.
[5] 张楠,莫小兰,魏雪芹等.原发性肾病综合征患儿合并肺炎的病原学特点及抗感染药物分析[J].河北医科大学学报,2023,44(6):729-732.
[6] 庞晓,冯超凡,王义香等.哌拉西林钠舒巴坦钠联合盐酸氨溴索治疗2型糖尿病合并细菌性肺炎患者的临床效果及对肺功能的影响分析[J].中国实用医药,2021,16(35): 18-21.
[7] 李晓艳.甘露消毒丹加减治疗配合抗感染药物治疗湿热蕴肺型小儿支原体肺炎对炎症反应的改善作用[J].黑龙江中医药,2020,49(6):109-110.
[8] 郑豪,张葆青,周旭.甘露消毒丹及其拆方对肺炎支原体干预的NR8383细胞炎症因子表达的影响[J].中国医药导报,2023,20(18):4-9.
[9] 王晓,贺红安,张葆青.基于网络药理学和分子对接探讨甘露消毒丹治疗肺炎支原体肺炎的机制[J].中国现代应用药学,2022,39(3):343-351.